Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

View:
Post by thePlayer on Jun 15, 2013 12:20am

Silver

lining, let me put this way: you simply can't be a real shareholder who like us went through all of this

during so many years. You simply can't. You must be a Fraud buddy.

Comment by silvarline on Jun 15, 2013 2:04pm
We'll see who the fraud(s) are come voting day ... this should be interesting. Let me repeat, Bioniche is not for FREE!  While the G-W gang and the Stockhouse mouthpieces can only offer words, mere words, BNC and some the heavy weights are stepping up to the plate, not just words but with dollars ,,, oh, and all in good faith too.  $$$$$  PLUS  I-N-T-E-G-R-I ...more  
Comment by peasoupfog on Jun 15, 2013 2:22pm
This post has been removed in accordance with Community Policy
Comment by Nohandledzep on Jun 15, 2013 3:23pm
Pea...It means that the share price trades at 1 x revenue, with no value recognized  for Urocidin, Econiche or the VMC.   It means that the current regime can't even get a multiple recognized for recurring revenue let alone get a penny  of value built in for the 200,000,000 spend on Urocidin, Econiche and the VMC. It means that the market couldn't care less. As a matter of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities